These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 26772531)
21. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis. Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543 [TBL] [Abstract][Full Text] [Related]
22. AICAR induces cyclooxygenase-2 expression through AMP-activated protein kinase-transforming growth factor-beta-activated kinase 1-p38 mitogen-activated protein kinase signaling pathway. Chang MY; Ho FM; Wang JS; Kang HC; Chang Y; Ye ZX; Lin WW Biochem Pharmacol; 2010 Oct; 80(8):1210-20. PubMed ID: 20615388 [TBL] [Abstract][Full Text] [Related]
23. Activation of cardiac AMPK-FGF21 feed-forward loop in acute myocardial infarction: Role of adrenergic overdrive and lipolysis byproducts. Sunaga H; Koitabashi N; Iso T; Matsui H; Obokata M; Kawakami R; Murakami M; Yokoyama T; Kurabayashi M Sci Rep; 2019 Aug; 9(1):11841. PubMed ID: 31413360 [TBL] [Abstract][Full Text] [Related]
24. Thyroid hormone improves the mechanical performance of the post-infarcted diabetic myocardium: a response associated with up-regulation of Akt/mTOR and AMPK activation. Mourouzis I; Giagourta I; Galanopoulos G; Mantzouratou P; Kostakou E; Kokkinos AD; Tentolouris N; Pantos C Metabolism; 2013 Oct; 62(10):1387-93. PubMed ID: 23773982 [TBL] [Abstract][Full Text] [Related]
25. Activation of AMP-activated protein kinase enhances angiotensin ii-induced proliferation in cardiac fibroblasts. Hattori Y; Akimoto K; Nishikimi T; Matsuoka H; Kasai K Hypertension; 2006 Feb; 47(2):265-70. PubMed ID: 16380538 [TBL] [Abstract][Full Text] [Related]
26. AMPK signalling and the control of substrate use in the heart. Nagendran J; Waller TJ; Dyck JR Mol Cell Endocrinol; 2013 Feb; 366(2):180-93. PubMed ID: 22750050 [TBL] [Abstract][Full Text] [Related]
27. Ischemic postconditioning regulates cardiomyocyte autophagic activity following ischemia/reperfusion injury. Guo L; Xu JM; Mo XY Mol Med Rep; 2015 Jul; 12(1):1169-76. PubMed ID: 25816157 [TBL] [Abstract][Full Text] [Related]
28. The extracellular matrix in myocardial injury, repair, and remodeling. Frangogiannis NG J Clin Invest; 2017 May; 127(5):1600-1612. PubMed ID: 28459429 [TBL] [Abstract][Full Text] [Related]
29. Exendin-4 attenuates cardiac hypertrophy via AMPK/mTOR signaling pathway activation. Zhou Y; He X; Chen Y; Huang Y; Wu L; He J Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):394-9. PubMed ID: 26519882 [TBL] [Abstract][Full Text] [Related]
30. AMPK attenuates microtubule proliferation in cardiac hypertrophy. Fassett JT; Hu X; Xu X; Lu Z; Zhang P; Chen Y; Bache RJ Am J Physiol Heart Circ Physiol; 2013 Mar; 304(5):H749-58. PubMed ID: 23316058 [TBL] [Abstract][Full Text] [Related]
31. Targeting the energy guardian AMPK: another avenue for treating cardiomyopathy? Li T; Jiang S; Yang Z; Ma Z; Yi W; Wang D; Yang Y Cell Mol Life Sci; 2017 Apr; 74(8):1413-1429. PubMed ID: 27815596 [TBL] [Abstract][Full Text] [Related]
33. AICAR stimulates IL-6 production via p38 MAPK in cardiac fibroblasts in adult mice: a possible role for AMPK. Du JH; Xu N; Song Y; Xu M; Lu ZZ; Han C; Zhang YY Biochem Biophys Res Commun; 2005 Dec; 337(4):1139-44. PubMed ID: 16229818 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway. Kuwabara Y; Horie T; Baba O; Watanabe S; Nishiga M; Usami S; Izuhara M; Nakao T; Nishino T; Otsu K; Kita T; Kimura T; Ono K Circ Res; 2015 Jan; 116(2):279-88. PubMed ID: 25362209 [TBL] [Abstract][Full Text] [Related]
35. Carnosol suppresses cardiomyocyte hypertrophy via promoting the activation of AMPK pathway. Tian Y; Liu R; Yang Q; Zhang J; Liu Z; Dong B; Gao J; Wan L Biochem Biophys Res Commun; 2024 Oct; 729():150343. PubMed ID: 38986259 [TBL] [Abstract][Full Text] [Related]
36. Metformin attenuates pressure overload-induced cardiac hypertrophy via AMPK activation. Fu YN; Xiao H; Ma XW; Jiang SY; Xu M; Zhang YY Acta Pharmacol Sin; 2011 Jul; 32(7):879-87. PubMed ID: 21552292 [TBL] [Abstract][Full Text] [Related]
37. Omentin functions to attenuate cardiac hypertrophic response. Matsuo K; Shibata R; Ohashi K; Kambara T; Uemura Y; Hiramatsu-Ito M; Enomoto T; Yuasa D; Joki Y; Ito M; Hayakawa S; Ogawa H; Kihara S; Murohara T; Ouchi N J Mol Cell Cardiol; 2015 Feb; 79():195-202. PubMed ID: 25479337 [TBL] [Abstract][Full Text] [Related]
38. Stimulation of cardiomyogenesis of embryonic stem cells by nitric oxide downstream of AMP-activated protein kinase and mTOR signaling pathways. Padmasekar M; Sharifpanah F; Finkensieper A; Wartenberg M; Sauer H Stem Cells Dev; 2011 Dec; 20(12):2163-75. PubMed ID: 21470048 [TBL] [Abstract][Full Text] [Related]
39. Thrombospondins in the transition from myocardial infarction to heart failure. Kirk JA; Cingolani OH J Mol Cell Cardiol; 2016 Jan; 90():102-10. PubMed ID: 26686988 [TBL] [Abstract][Full Text] [Related]
40. Metformin inhibits aldosterone-induced cardiac fibroblast activation, migration and proliferation in vitro, and reverses aldosterone+salt-induced cardiac fibrosis in vivo. Mummidi S; Das NA; Carpenter AJ; Kandikattu H; Krenz M; Siebenlist U; Valente AJ; Chandrasekar B J Mol Cell Cardiol; 2016 Sep; 98():95-102. PubMed ID: 27423273 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]